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Abstract
Background: The early-life gut microbiota plays a critical role in host metabolism in later life. However, little is known
about how the fatty acid profile of the maternal diet during gestation and lactation influences the development of the
offspring gut microbiota and subsequent metabolic health outcomes.
Results: Here, using a unique transgenic model, we report that maternal endogenous n-3 polyunsaturated fatty acid
(PUFA) production during gestation or lactation significantly reduces weight gain and markers of metabolic disruption
in male murine offspring fed a high-fat diet. However, maternal fatty acid status appeared to have no significant effect
on weight gain in female offspring. The metabolic phenotypes in male offspring appeared to be mediated by
comprehensive restructuring of gut microbiota composition. Reduced maternal n-3 PUFA exposure led to
significantly depleted Epsilonproteobacteria, Bacteroides, and Akkermansia and higher relative abundance of
Clostridia. Interestingly, offspring metabolism and microbiota composition were more profoundly influenced by
the maternal fatty acid profile during lactation than in utero. Furthermore, the maternal fatty acid profile
appeared to have a long-lasting effect on offspring microbiota composition and function that persisted into
adulthood after life-long high-fat diet feeding.
Conclusions: Our data provide novel evidence that weight gain and metabolic dysfunction in adulthood is
mediated by maternal fatty acid status through long-lasting restructuring of the gut microbiota. These results
have important implications for understanding the interaction between modern Western diets, metabolic
health, and the intestinal microbiome.
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Background
The gut microbiota is a complex microbial ecosystem lin-
ing the intestinal tract that critically regulates host metab-
olism, immune responses and a number of other key
physiological pathways [1–3]. The composition and func-
tion of the gut microbiota is profoundly influenced by en-
vironmental factors such as diet, mode of delivery at birth
and antibiotic usage [4, 5]. Due to the essentiality of the
commensal microbiota in host physiological homeostasis,
environmental disturbance of gut microbiota composition
and function can play a causal role in weight gain and
metabolic dysfunction [3, 4, 6]. The microbiota is primar-
ily established at birth through vertical transmission from
the mother, while some reports also indicate microbial ex-
posures in utero [7–9]. Indeed, the maternal vaginal
microbiota closely resembles that of the infant microbiota
soon after birth [7, 10]. Hence, disruption of the initial
structuring of the microbiota in early-life may interfere
with host metabolism and increase risk of later-life meta-
bolic disease.
Disruption of the normal gut microbiota composition
(“dysbiosis”) is often characterized by elevated relative abun-
dance of pathogenic bacteria, such as lipopolysaccharide
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(LPS)-producing Enterobacteriaceae, or depletion of
commensal species that maintain gut homeostasis, such
as Akkermansia muciniphilia [11–13]. Recent research
has examined how mode of delivery at birth, breast-
feeding duration, and antibiotic use influence this
structuring of the offspring microbiota [4, 14]. How-
ever, little is known about how the maternal prenatal or
early-postnatal diet affects the phylogenetic architec-
ture of the offspring microbiota and the subsequent ef-
fects this may have for metabolic disease risk in later
life. Indeed, maternal nutritional inadequacies adversely
affect fetal metabolic programming in the offspring
leading to negative health consequences in later life
[15]; however, the role of the microbiota in this trans-
generational process remains underexplored.
Previous research has shown that a parental Western
diet is associated with elevated plasma LPS and height-
ened colonic immune responses in standard chow-fed off-
spring [16]. These immune-modulating responses are
dependent upon the comprehensive changes induced to
the offspring microbiota, as a result of the parental diet.
Indeed, maternal high-fat diets also induce compositional
changes to the offspring microbiota in non-human pri-
mates [17]. Consequently, as the maternal microbiota cor-
relates with that of the infant [7], optimization of maternal
diet and microbiota composition may therefore enhance
infant microbiota development.
Although it has been shown that high-fat diets contrib-
ute to perturbation in gut microbial balance and
inflammation-induced obesity, recent evidence suggests
that saturated and polyunsaturated fatty acids (PUFA) dif-
fer in their interaction with the gut microbiota and subse-
quent metabolic outcomes [18, 19]. Omega-3 (n-3) and
omega-6 (n-6) PUFA play opposing roles in the inflamma-
tory response [20]. n-6 PUFA typically upregulate inflam-
mation by acting as precursors to pro-inflammatory
eicosanoids, while n-3 PUFA resolve inflammation by com-
peting within the same enzymatic pathway. The evolution-
ary ratio of n-6/n-3 PUFA has been estimated at 1:1;
however, this has increased to 10–50:1 in the modern west-
ern diet which many have suggested has contributed to the
epidemic of chronic inflammatory diseases such as obesity
[21]. Indeed, there is convincing evidence that lowering the
n-6/n-3 ratio can restore disrupted metabolism in the con-
text of chronic disease [22, 23]. From an early-life perspec-
tive, lowering the n-6/n-3 ratio in obese mothers can
reduce offspring weight gain and associated inflammatory
outcomes in mice [24]. Similar results have been reported
for improving insulin sensitivity [25]. Furthermore, obser-
vational and intervention studies in humans have found
negative correlations for n-3 PUFA status and positive cor-
relations for n-6 status and offspring adiposity [26, 27].
Indeed, n-6 and n-3 PUFA appear to have opposing
effects on intestinal homeostasis. We have recently
reported that, relative to dietary n-6 PUFA, n-3 PUFA
reduce Enterobacteriaceae relative abundance, elevate
relative Bifidobacterium abundance, and dampen intes-
tinal inflammation partially through the upregulation of
certain anti-microbial peptides in mice [28, 29]. Simi-
larly, n-3 PUFA deficiency induces a state of gut dysbio-
sis through alteration of gut microbiota composition and
impairment of short-chain fatty acid production [30].
Changes to gut microbiota composition induced by
omega-3 deficiency in mice are also associated with be-
havioral impairments even before adolescence, suggest-
ing an essential role for n-3 PUFA within the developing
gut-brain axis [31].
Data on the role of maternal n-3 PUFA on offspring
microbiota are limited. Some evidence suggests that high
doses of maternal fish oil supplementation impair the
immune response in offspring and lead to the over-
growth of pathogenic bacteria [32]. However, these stud-
ies utilized crude fish oil in pharmacologically excessive
doses (18% energy), and hence, further studies are war-
ranted to examine the relationship between nutritionally
relevant maternal n-3 PUFA intake and offspring micro-
biota. In addition, the role of maternal n-3 PUFA intake
in the context of offspring obesity and its association
with gut microbiota has not been previously examined.
Furthermore, there is a lack of evidence as to the differ-
ences between pre- and postnatal n-3 PUFA status for
offspring metabolic health.
Based on previous evidence reporting the critical
opposing roles that n-3 and n-6 PUFA play in
microbiota-associated metabolic endotoxemia [28], we
aim to investigate this in the context of maternal n-6/n-3
PUFA status and subsequent effects on obese offspring.
To examine this, we utilize the fat-1 transgenic mouse
model, which is capable of endogenous conversion of n-6
PUFA to n-3 PUFA [33] and thereby eliminates confound-
ing factors of diet. Therefore, using a single diet for both
treatment groups, this model allows the generation of two
phenotypes: (a) fat-1 mice with a balanced tissue n-6/n-3
ratio (~ 1:1) and (b) wild-type (WT) mice with a high n-6/
n-3 ratio similar to the Western diet (> 10:1). By examin-
ing the WT offspring of these two maternal genotypes
and cross-fostering the offspring to mothers of different
genotype at birth, we are able to identify the effect of ma-
ternal n-3 PUFA status during gestation and/or lactation
on offspring health outcomes. Our results show that a
lower maternal n-6/n-3 ratio during gestation and/or lac-
tation significantly reduces weight gain and metabolic dis-
ruption in offspring fed a high-fat diet (HFD), which
appears to be mediated through persistent restructuring
of the gut microbiota. These studies provide novel evi-
dence for the critical role of the maternal diet in early-life
gut microbiota development and the subsequent impact
on later-life metabolic disease states.
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Results
Maternal fatty acid status during gestation and lactation
differentially modulate offspring fatty acid profile
To examine the effects of varying maternal fatty acid
status during gestation and lactation on the tissue fatty
acid profile of offspring, we created a cross-fostering
protocol and measured offspring fatty acid composition
at different time points (Fig. 1). Tissue fatty acid profiles
of WT and transgenic fat-1 mothers were assessed in
addition to their WT offspring at weaning (4 weeks old)
and following 3 months of HFD feeding (Fig. 1a). As ex-
pected, the n-6/n-3 PUFA ratio in tail tissue was signifi-
cantly greater in WT mothers than in fat-1 mothers
(p < 0.0001, Fig. 1b). Maternal fatty acid profiles ap-
peared to be transferred to offspring whereby, following
4 weeks of lactation, male offspring whom had a WT
mother during both gestation and lactation (WT/WT)
displayed a significantly greater n-6/n-3 ratio compared
with all other groups (p < 0.0001, Fig. 1c). Conversely,
offspring whom had a transgenic fat-1 mother during
both perinatal periods (fat-1/fat-1) displayed the lowest
tail n-6/n-3 ratio. Interestingly, in the crossover groups,
WT/fat-1 offspring (those who had a WT mother during
gestation and a fat-1 mother during lactation) had a sig-
nificantly lower n-6/n-3 ratio than fat-1/WT offspring,
suggesting that the maternal fatty acid profile during lac-
tation had a more pronounced effect on the offspring
fatty acid profile than the maternal fatty acid profile dur-
ing gestation.
Interestingly, differences in adolescent tail n-6/n-3 ra-
tio as a result of maternal genotype were eliminated fol-
lowing 3 months of HFD feeding (Fig. 1d), and similarly,
there were also no differences in n-6/n-3 PUFA ratio in
offspring liver (Additional file 1: Table S3).
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Fig. 1 Experimental design and tail fatty acid profiles. a fat-1 (n = 15) and WT mothers (n = 9) were mated while on a high-n-6 PUFA diet (10%
corn oil). At birth, WT offspring were cross-fostered to different mothers for the period of lactation (4 weeks) to produce four experimental groups
based on the mothers’ genotype (biological mother’s genotype/foster mother’s genotype): fat-1/WT (n = 8 males, n = 7 females), WT/fat-1 (n = 9
males, n = 10 females), fat-1/fat-1 (n = 9 males, n = 5 females), and WT/WT (n = 10 males, n = 10 females). During lactation, mothers were continued on
a high-n-6 PUFA diet. After 4 weeks of lactation, offspring were weaned onto a high-fat diet (HFD) (60% kcal from fat) for 3 months during which body
weights were assessed along with a number of other parameters. b WT mothers displayed a significantly greater tail n-6/n-3 ratio compared with fat-1
mothers. c Following lactation for 4 weeks and prior to HFD, WT/WT male offspring had significantly greater tail n-6/n-3 ratio compared with all other
groups. d However, after 3 months on a HFD, differences in tail n-6/n-3 fatty acid ratio were eliminated and there were no significant differences
between groups. Data shown as mean ± SEM. n = 5–15 per group, n = 1–4 per cage. Bars with different letters are significantly different
Robertson et al. Microbiome  (2018) 6:95 Page 3 of 14
Perinatal n-3 PUFA exposure reduces weight gain under
high-fat diet
To examine whether maternal fatty acid status affects off-
spring weight gain, offspring of WT and fat-1 were fed a
HFD (60% kcal from fat) for 3 months. There were no sig-
nificant differences in offspring weights at week 4 prior to
introduction of the HFD. In female offspring, there were
no significant differences in weight gain between groups
following 3 months HFD feeding (Fig. 2a, b). However, at
10 weeks of age and following 6 weeks of HFD feeding,
WT/WT males had gained significantly more weight than
WT/fat-1 males (p < 0.05) suggesting that the influence of
maternal n-3 PUFA status on offspring weight gain is
gender-dependent. This effect of maternal fatty acid status
on male offspring weight gain was strengthened with con-
tinuation of the HFD whereby WT/WT continued to gain
significantly more weight than all other groups through-
out the experimental period (Fig. 2c). At sacrifice, follow-
ing 3 months of HFD, WT/WT mice had gained 232%
body weight, which was significantly greater (p = 0.012)
than all other groups (fat-1/WT—189%; WT/fat-1—195%;
fat-1/fat-1—197%; Fig. 2d). Importantly, food intake did
not differ significantly between groups. There were also
no significant differences in body composition between
groups (Additional file 1: Figure S1).
Maternal n-3 PUFA dampen markers of metabolic
disruption in offspring fed a high-fat diet
We then examined markers of metabolic disruption follow-
ing HFD feeding to assess whether differences in offspring
weight gain induced by maternal n-3 PUFA availability me-
diated metabolic health. Lipopolysaccharide-binding pro-
tein (LBP), a marker of metabolic endotoxemia, was lowest
in fat-1/fat-1 offspring (p < 0.05, Fig. 2e). Intestinal perme-
ability (IP) is a measure of gut epithelial integrity relating to
the passage of microbial endotoxins such as LPS into circu-
lation. Again, the fat-1/fat-1 group exhibited the lowest IP
(p = 0.05, Fig. 2f). However, at this time point, there were
no observed differences between groups in concentrations
of circulating serum cytokines IL-10, IL-1β, IL-6, MCP-1,
or TNFα (Additional file 1: Figure S2A-E). Analysis of sub-
cutaneous adipose tissue inflammation revealed no differ-
ences in mRNA expression of TNFa, F4/80 or CCL2;
however, TLR4 expression was lower (p < 0.05) in fat-
1/WT compared with both fat-1/fat-1 and WT/WT
(Additional file 1: Figure S2F-I).
There were subtle differences in glucose tolerance pre-
HFD whereby WT/WT offspring had significantly
greater circulating glucose (p < 0.05) at two time points
during a glucose tolerance test (GTT). These differences
were eliminated following HFD feeding (Additional file 1:
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Fig. 2 Weight gain and metabolic markers on a HFD. a, b There were no differences in weight gain between female groups. c, d WT/WT male
offspring gained significantly more weight on a HFD than all other groups (repeated-measures two-way ANOVA (time and group) with Tukey’s
post-hoc test). e Fat-1/fat-1 displayed the lowest circulating LBP and intestinal permeability (f). Data shown as mean ± SEM. fat-1/WT: n = 8 males,
n = 7 females; WT/fat-1: n = 9 males, n = 10 females; fat-1/fat-1: n = 9 males, n = 5 females; WT/WT: n = 10 males, n = 10 females. n = 1–4 animals
per cage. Bars with different letters are significantly different. *p < 0.05 and **p < 0.01, WT/WT vs. WT/fat-1; #p < 0.05 and ##p < 0.01 WT/WT vs
fat-1/WT; &p < 0.05, WT/WT vs. fat-1/fat-1
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Figure S3A-C). Insulin sensitivity also appeared to be
differentially regulated post-HFD with the fat-1/fat-1
group displaying the lowest insulin area under the curve
(AUC) following glucose administration (p = 0.02,
Additional file 1: Figure S3D-H).
Maternal n-3 PUFA status has a profound influence on
offspring microbiota composition in early life, which
persists into adulthood
To examine whether differences in weight and metabolic
health between offspring groups were mediated by changes
in the gut microbiota, 16S rRNA gene sequencing was per-
formed on fecal DNA of mothers and offspring both pre-
and post-HFD feeding. 16S rRNA gene sequencing of the
mothers’, offspring pre-HFD, and post-HFD fecal micro-
biota generated a total of 23 million sequenced reads. Prin-
cipal coordinate analysis (PCoA) revealed distinct
clustering of WT and fat-1 mothers based on microbiota
composition (Additional file 1: Figure S5A). Whole micro-
biome significance testing using PERMANOVA with Bray-
Curtis dissimilarity index showed significant differences
between fat-1 and WT mothers (p = 0.0044, F = 4.874;
Additional file 1: Figure S5A). In the offspring, clustering
was evident among treatment groups, as assessed using
PERMANOVA with Bray-Curtis dissimilarity index both
pre-HFD (p = 0.0006; F = 3.497) and post-HFD (p = 0.
0001, F = 9.821; Fig. 3a). Both prior to and after HFD
feeding, offspring clustered significantly according to
the foster mother’s genotype such that the fat-1/WT
and WT/WT groups clustered together, and the fat-1/
fat-1 and WT/fat-1 groups clustered together, accord-
ing to Bray-Curtis dissimilarity index testing. Assess-
ment of α-diversity using the Shannon Index revealed
no significant differences between WT and fat-1
mothers (Additional file 1: Figure S5B) or between
post-HFD groups (Fig. 3b). However, microbial diver-
sity as measured by the Shannon Index was signifi-
cantly reduced in the WT/WT group compared with
WT/fat-1 prior to HFD feeding (Fig. 3b).
Relative abundances of phylum level taxa revealed dis-
tinct differences between groups (Fig. 3c, d). In mothers,
Proteobacteria was the only phylum significantly differ-
ent between groups following FDR correction (p = 0.05)
and was present in greater relative abundance in fat-1
females (Additional file 1: Figure S5C). Taxonomic dis-
tribution appeared to be most significantly influenced by
lactating/foster mother’s genotype as opposed to bio-
logical mother’s genotype. Hence, Proteobacteria was
significantly greater in both WT/fat-1 and fat-1/fat-1
offspring both pre-HFD (p = 0.018) and post-HFD (p <
0.001). Verrucomicrobia were also highest in fat-1/fat-1
offspring post-HFD (p = 0.023). Conversely, Firmicutes
were significantly greater in fat-1/WT and WT/WT off-
spring post-HFD (p < 0.001).
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Fig. 3 Phylum compositional and diversity differences in fecal microbiota between offspring of fat-1 and WT mothers. a Analysis of beta diversity
identified significant clustering of offspring groups by foster maternal genotype. b α-diversity as measured by the Shannon index did not differ
between post-HFD groups, however, appeared to be reduced in WT/WT compared with WT/fat-1 before HFD feeding. c The Firmicutes:Bacteroidetes
ratio was lowest in fat-1/fat-1 offspring. d Fecal microbiota composition differed significantly between offspring groups at phylum level and appeared
dependent on foster mother genotype. Significant differences were determined by non-parametric analysis using the Kruskall-Wallis test followed by
Mann-Whitney test. n = 5–10 per group, n = 1–4 per cage. Groups with different letters are significantly different
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Due to the significant PCoA clustering between groups
based on foster mother’s genotype, offspring were grouped
according to the foster mother’s genotype and linear dis-
criminant analysis effect size (LEfSe) was performed on
these two groups (1. WT/fat-1 + fat-1/fat-1; 2. fat-1/WT +
fat-1/fat-1) as a biomarker discovery tool to identify taxa
that may be contributing to differences between groups
(Fig. 4a and Additional file 1: Figure S4). LEfSe analysis elu-
cidated the observed phylum level differences such that off-
spring whom had a WT foster mother were more abundant
in species within the Firmicutes phylum (Clostridia) and
offspring whom had a fat-1 foster mother were more abun-
dant in species of the Bacteroidetes (primarily Bacteroides)
and Proteobacteria phyla (primarily Epsilonproteobacteria)
(Additional file 1: Figure S5).
Further analysis at lower taxonomic levels revealed a
number of taxa (13 genera pre-HFD and 26 genera post-
HFD) that appeared to significantly differ between groups
(Fig. 4b). Clostridia and Parabacteroides were significantly
greater in fat-1/WT and WT/WT offspring post-HFD
(Fig. 4c). Conversely, Akkermansia appeared to be signifi-
cantly elevated in fat-1/fat-1 offspring post-HFD. Bacter-
oides were also significantly lower in offspring with WT
foster mothers. Interestingly, the reduced Proteobacteria
observed in WT mothers and offspring fostered to WT
mothers was driven primarily by depleted Epsilonpro-
teobacteria (Fig. 4c) and Deltaproteobacteria, whereas
relative abundance of Gammaproteobacteria was un-
changed (Additional file 1: Figure S5). Helicobacter, a
commensal member of the Epsilonproteobacteria order,
Fig. 4 Genus level distribution of fecal microbiota between offspring of fat-1 and WT mothers. a Least discriminant analysis of effect size (LEfSe)
on clustered groups based on maternal genotype revealed that Firmicutes were more abundant in offspring of WT foster mothers whereas
Bacteroidetes and Proteobacteria were more abundant in offspring of fat-1 foster mothers. b Normalized data of fecal microbiota relative
abundance revealed distinct differences between offspring groups. Microbiota composition appeared similar in groups of the same foster
mother genotype. Data represents OTUs with significantly different relevant abundances between treatment groups (as determined by Kruskall-Wallis
testing and Benjamani-Hocherg multiple correction testing). Each row represents an OTU labeled by lowest taxonomic description and OTU ID,
normalized to the row maximum. Data normalized per taxonomic read. c Clostridia displayed significantly higher relative abundance in
offspring of WT foster mothers. Bacteroides displayed higher relative abundance in offspring of fat-1 foster mothers. Akkermansia displayed
the highest relative abundance in fat-1/fat-1 offspring. Epsilonproteobacteria were almost entirely depleted (< 0.1%) in offspring fostered to
WT mothers. n = 5–10 per group, n = 1–4 per cage. Significant differences were determined by non-parametric analysis using the Kruskall-Wallis test
followed by Mann-Whitney test and FDR correction by Benjamani-Hochburg testing. Groups with different letters are significantly different
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which constituted 9–14% of the fat-1/fat-1 and WT/fat-1
post-HFD microbiota, was almost entirely depleted
(< 0.1%) in offspring of WT foster mothers.
Network interactions reveal host-microbiome interactions
driven by fatty acid status
To assess the overall measure of correlation between the
n-6/n-3 ratio-induced metabolic changes and micro-
biota, an RV coefficient was calculated. An RV coeffi-
cient of 0.456 (p = 0.001) was found between the relative
abundance of microbial genera (pre- and post-HFD) and
host phenotypes (mother and offspring pre-HFD n-6/n-3
ratio, LBP, IP, and total body weight gain).
Network-based analytical approaches have the poten-
tial to help disentangle complex host-microbe interac-
tions [34]. Pairwise correlations between offspring n-6/
n-3-induced changes in microbiota and host parameters
with significant Spearman’s non-parametric rank correl-
ation coefficient were employed to generate correlation
networks for both pre-HFD and post-HFD (Fig. 5a, b).
Correlation analysis with pre-HFD microbiota data re-
sulted in a correlation network of 92 microbial parame-
ters (taxa and α-diversity indices) and 4 host parameters
(pre-HFD n-6/n-3 ratio, final body weight gain, LBP, and
IP) for which at least one correlation could be found.
The network consists of 118 edges (70 and 48 positive
(green) and negative correlations (red) respectively) and
98 nodes (microbial and host parameters). Three mod-
ules were observed in the pre-HFD network (1. n-6/n-3
ratio; 2. weight + LBP; 3. IP). Accordingly, the largest
module (n-6/n3 ratio) showed high modularity (blue
nodes) comprised of both positive (P; red lines) and
negative correlations (N; green lines) with a number of
taxa, namely Firmicutes (P), Bacteroidetes (N), Proteobac-
teria (N), Clostridia (P), Epsilonproteobacteria (N), Rumi-
nococcaceae (P), Porphyromonadaceae (N), Bacteroides
(N), and Akkermansia (P) (Fig. 5a). A number of similar
outcomes persisted in the post-HFD correlation network,
whereby body weight was negatively associated with Pro-
teobacteria and LBP negatively correlated with Akkerman-
sia (Fig. 5b). Networks were also constructed between
mother’s n-6/n-3 ratio, pre- and post-HFD microbiota
data, and host parameters (Additional file 1: Figure S7).
To further investigate the identified groups of correla-
tions between changes in microbiota composition and host
parameters, we built partial least squares (PLS) models for
selected correlations of interest created (Additional file 2;
Goodness of fit—Q2cum > 0.8). Combination of offspring
pre-HFD n-6/n-3 ratios and all microbiota data explained
68, 72, and 61% variability in the body weight gain, LBP,
and IP, respectively (Additional file 2: data models 4–6). A
model created between all the host parameters (weight
gain, LBP, and IP) and all microbiota data and mothers and
offspring n-6/n-3 ratio (model 12) explained 45, 32, and
35% variability in the host parameters respectively (Fig. 5c).
Variable importance in the projection (VIP) scores for the
variables in each PLS model can be found in the Supple-
mentary Data File 6 (M1–14).
Next, parameters contributing to the multivariate PLS
models were compared with the corresponding identi-
fied modules in the correlation networks. Notably, 42
out of 50 pre-HFD microbial parameters, which exhib-
ited direct correlations with offspring n-6/n-3 ratio in
the network analysis (largest module), were presented
with VIP values 1 or > 1 in the PLS model (model 8).
The selected microbial parameters have been shown
with R2 and VIP scores in the Supplementary data File 6
(M8). Twenty-eight out of 44 pre-HFD and 6 out of 9
post-HFD microbial parameters having correlations with
mother’s n-6/n-3 ratio and LBP in the network analysis
(largest module in the pre- and post-HFD networks)
were presented with VIP values 1 or > 1 in the PLS
model (model 3 and M3).
Finally, this was visualized using multiple factor analysis
(MFA) that allowed microbial parameters to be superim-
posed onto the host parameters (Fig. 5d). Superimposed
microbiome and host data were separated depending
upon the n-6/n-3 ratio of both mother and foster mother.
Pairwise comparison (Monte Carlo simulations with a
P value = 0.008) between groups with superimposed
host and microbiota data showed the importance of
lactating mothers n-6/n-3 ratio when offspring were
born from WT mothers.
Discussion
In this study, we observed that the perinatal maternal
tissue fatty acid profile profoundly and persistently re-
structures the offspring gut microbiota, which may have
long-term implications for metabolic health. Maternal n-
3 PUFA significantly reduced offspring weight gain into
adulthood during high-fat feeding as has been demon-
strated previously in humans and animals [26, 35, 36]. A
number of mechanisms may contribute to this. Firstly,
maternal tissue and milk n-3 PUFA correlate with um-
bilical cord and infant n-3 PUFA [37, 38]; therefore, the
beneficial effects on weight may be attributed to direct
nutrient transport from mother to infant and the subse-
quent anti-adipogenic effects of n-3 PUFA [39]. The in-
triguing aspect of these findings is that the fat-1/WT
group had a higher n-6/n-3 ratio than the WT/fat-1
group, suggesting that the offspring n-3 status is more
influenced by the dietary n-3 PUFA during lactation, via
milk, rather than maternal n-3 PUFA status during ges-
tation. It has previously been reported that n-3/n-6 con-
tent in milk from fat-1 females is greater than WT
females [33]. Additionally, there appeared to be a strong
gender difference between male and female offspring re-
garding weight gain as a result of maternal n-3 status.
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Maternal n-3 PUFA reduced weight gain in offspring
males but not females. Such gender-dependent differ-
ences have been reported previously in humans, an ef-
fect which may be mediated by the interaction of female
sex hormones with adipogenesis and fatty acid metabol-
ism [40–42].
We also observed that maternal fatty acid status influ-
enced immune regulation in the offspring, which may
affect weight. It appeared that the lower n-6/n-3 ratio in
fat-1 mothers may have dampened maternal and placental
inflammation, which induced an anti-inflammatory and
anti-obesigenic environment in the offspring. This effect of
maternal tissue fatty acid status on offspring inflammation
has been demonstrated previously. Using the same fat-1
model, it has been shown that maternal obesity induces
maternal and placental inflammation, which is transmitted
to the offspring resulting in a number of metabolic disrup-
tions that are not evident in offspring of fat-1 mothers
[24]. Indeed, in this study, both IP and LBP were signifi-
cantly reduced by maternal n-3 PUFA. This interesting
finding suggests that the chronic low-grade inflammation
that mediates the obesigenic phenotype [43] may be trans-
ferred from the mother to the infant during the perinatal
period. This inflammatory phenotype appears to originate
in the intestines through degradation of the intestinal bar-
rier and hence translocation of bacterial endotoxins.
c d
a b
Fig. 5 Network analyses of microbiome and host metabolic phenotype interactions. Host-microbiota interaction network built from Spearman’s
non-parametric rank correlation coefficient (P < 0.05) between host parameters (mother and offspring pre-HFD n-6/n-3 ratio, body weight, IP, and
LBP) and microbial parameters (pre- and post-HFD OTUs with FDR-corrected p values < 0.05, FIR/BAC ratio, and Shannon ADI) for a pre-HFD and
b post-HFD. Each node was colored according to the modularity score and nodes were grouped as three (a) or four (b) modules. Lines represent
statistically significant correlations and are colored red for positive and green for negative correlations. c Partial least square (PLS)-regression loading
score plot illustrating the association between host parameters (dependent variables—Y) and microbial parameters (explanatory variables—X; red dots).
Explanatory variables of interest with variable importance in the projection (VIP) scores 1 or > 1 were labeled with circles on the red dots. Samples from
four different groups (fat-1/WT, WT/fat-1, fat-1/fat-1, WT/WT) were observed (green dots) and grouped using circles based on where they clustered on
the plot. Leave-one-out cross-validation (LOO-CV) was applied. d Multiple factor analysis (MFA) using Spearman type principal component analysis of
host and microbiota data. One end of the each connecting line for an observation indicates the host parameters (differently colored to indicate the
groups) and another end (red) indicates the microbiota
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As has been reported previously, this inflammatory
phenotype is induced by a disturbed microbiota [19, 44].
The composition of an infant’s microbiota is strongly in-
fluenced by that of the mother [7]. Therefore, the anti-
inflammatory fat-1 microbiota that has been described
previously [28] may have been transmitted vertically to
the offspring thereby reducing the microbiota-associated
weight gain. The gut microbiota has a well-established
role in energy metabolism and obesity by regulating en-
ergy harvest from macronutrients [6]. Interestingly, the
observed differences in weight gain in this study were in-
dependent of dietary intake, which did not differ, sug-
gesting that the WT/WT microbiota displayed an
increased capacity for energy harvest. Previous hypoth-
eses surrounding the “obesigenic” microbiota have con-
centrated on the energy-harvesting capacity of
Firmicutes and the production of short-chain fatty acids
(SCFA). Indeed, we observed this effect here whereby
Firmicutes and their SCFA-producing families (Lachnos-
piraceae and Ruminococcaceae) were significantly greater
in WT mothers and their foster offspring. We have previ-
ously demonstrated that differing ratios of dietary fatty
acids significantly alter SCFA production in mice [30]. The
role of the microbiota in regulating gut epithelial integrity
and the subsequent inflammatory response has also been
hypothesized to play a role in obesity [45, 46]. Here, we ob-
served that IP and LBP were lowest in fat-1/fat-1 offspring.
These changes to IP were independent of changes to tight
junction protein expression (Additional file 1: Figure S6).
Conversely, Akkermansia was greater in offspring of fat-1
mothers and hence may mediate the protective effect of
maternal n-3 PUFA on weight gain in the offspring as has
been shown previously in fish oil-fed mice [19]. There is
growing evidence that Akkermansia plays a critical role in
metabolic health and can reduce weight gain and metabolic
endotoxemia in mice and humans [12, 13, 47]. Epsilonpro-
teobacteria, and its genus Helicobacter, were also signifi-
cantly depleted in offspring of WT foster mothers in
response to a lack of perinatal n-3 PUFA. Our data
extend on work of Ma et al. who reported that a mater-
nal HFD in primates induced loss of non-pathogenic
Helicobacter and Campylobacter, another member of
Epsilonproteobacteria, in offspring [17]. Interestingly,
offspring of non-human primates fed a high-fat diet ex-
hibit reduced plasma n-3 PUFA [48].
This unique model and study design also allowed us to
distinguish the role of the prenatal versus postnatal ma-
ternal tissue fatty acid profile on offspring outcomes.
Interestingly, as with the n-6/n-3 ratio, the gut micro-
biota of the offspring appeared to strongly match that of
the lactating/foster mother rather than the biological
mother. Indeed, it has previously been shown in cross-
fostering models that the nursing mother causes a per-
manent shift in the offspring microbiome [49]. It has
been assumed that the fetus is sterile; however, recent
studies may suggest otherwise [9]. The biological mother
imprints a unique microbiota on the infant at birth [7].
The results reported here suggest that the labile “birth
microbiota” is quickly and comprehensively altered by
the foster mother, presumably through differences in
milk/dietary fatty acids and the foster mother's micro-
biota following birth. These results would suggest that
n-3 PUFA status in milk during lactation has a stronger
impact on the infant microbiota than maternal fatty acid
status during gestation. Hence, postnatal n-3 PUFA ex-
posure may rescue and recover a “dysbiotic” offspring
microbiota induced by the maternal prenatal n-3 PUFA
insufficiency. Furthermore, despite the differences in n-3
and n-6 PUFA disappearing in adulthood after HFD, the
observed differences in the microbiota persisted, suggest-
ing that maternal fatty acid status and early neonatal feed-
ing regime may have a persistent effect on the offspring
microbiota throughout life.
Conclusions
Much evidence exists indicating that obesity and its as-
sociated disorders have their origins in the fetal and neo-
natal periods. As the gut microbiota plays a critical role
in the pathogenesis of these disorders and the chronic
low-grade inflammation that defines them, nutrition re-
search must now focus on maternal and early-life inter-
ventions that target the gut microbiota. This study has
demonstrated that maternal fatty acid status persistently
restructures the offspring microbiota and the associated
metabolic homeostasis related to obesity. In addition,
the unique transgenic model used here challenges the
concept of a direct diet-microbiota interaction in obesity
and instead uncovers the importance of the underlying
tissue fatty acid profile in microbiota-metabolic interac-
tions. These results have important implications for the
current chronic disease epidemic. Excessive n-6/n-3 ra-
tios in the Western diet have contributed to a trans-
generational epidemic of chronic metabolic disease,
which may be partially attributed to persistent gut
microbiota dysbiosis. Consequently, maternal n-3 PUFA
intake, especially during lactation, poses potential as an
effective therapeutic measure to restore gut microbiota
homeostasis and metabolic disturbances associated with
modern chronic disease.
Methods
Animals and diets
Generation of transgenic fat-1 mice was performed as pre-
viously described [33] followed by backcrossing onto a
C57BL/6 background. Fat-1 phenotype was confirmed by
gas chromatography flame-ionization detection (GC-FID)
following identification of increased tissue n-3 PUFA com-
pared with WT. Fat-1 genotype was confirmed by RT-
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PCR. Mice were housed in the Massachusetts General
Hospital (MGH) animal facility in a biosafety room (level
2) in hard top cages with filtered air. Mice were main-
tained in a temperature-controlled room (22–24 °C) with
a 12-h light/dark diurnal cycle. Food and water were pro-
vided ad libitum. A subset of 3-month-old female C57BL/
6 WT mice was purchased from Charles River Laborator-
ies and allowed to acclimatize to the facility conditions for
1 week prior to mating. Fat-1 and WT mating pairs were
fed a diet high in n-6 PUFA (AIN-76A with 10% corn oil)
from LabDiet in order to maintain fat-1 and WT pheno-
types. At postnatal day (PND) 28, male and female off-
spring were weaned onto a high-fat diet (HFD) with 60%
kcal from fat (D12492, Research Diets Inc.). Detailed fatty
acid profiles of both diets are outlined in Additional file 1:
Table S1. Body weight and food intake were measured
weekly using an electrical balance. Body composition (fat
mass, lean mass, water mass) was assessed on the day of
sacrifice using a Minispec mq bench-top NMR spectrom-
eter (Bruker Instruments). Animals were sacrificed using
CO2. Dissected tissues were flash frozen in liquid nitrogen.
All animal procedures in this study were performed in ac-
cordance with the guidelines approved by the MGH Sub-
committee on Research Animal Care.
Breeding and cross-fostering
Three-month-old female fat-1 (n = 15) and WT (n = 9)
mice were mated with age-matched WT males. Mating
pairs were housed in individual cages, and males were
separated from the females following confirmation of
pregnancy. Within 48-h of parturition, newborn litters
were fostered to new mothers until weaning, at PND 28.
Briefly, the newborn litter was removed from the bio-
logical mother’s cage then mixed with the bedding of the
foster mother in the hand of the investigator. The litter
was then placed in the empty nest of the new foster
mother. The foster mother was held above the new litter
until she urinated on the litter in order to disguise their
scent. The foster mother pairs were chosen such that
offspring were fostered to mothers whom had given
birth within 48 h to a litter of similar size. The cross-
fostering procedure was carried out in order to generate
offspring of four distinct experimental groups as follows:
n6-n3 group—WT biological mother, cross-fostered to
fat-1 mother; n3-n6 group—fat-1 biological mother,
cross-fostered to WT mother; n3-n3 group—fat-1 bio-
logical mother, cross-fostered to new fat-1 mother; n6-
n6 group – WT biological mother, cross-fostered to new
WT mother. Cross-fostering was carried out in the n3-
n3 and n6-n6 groups as a control to the cross-fostering
procedure in the other two groups. The study design is
outlined in Fig. 1.
At PND 10, the tails of the offspring were clipped with
a scissors and genotyping was performed on the tail
tissue by RT-PCR. Following confirmation of genotype,
fat-1 mice were removed from the litter such that only
the WT offspring remained. At PND28, WT offspring
were separated from their mothers, grouped in separate
cages (randomized by experimental group, n = 1–4 ani-
mals per cage, n = 3–4 cages per experimental group)
and weaned onto the HFD.
Fatty acid analysis
Fatty acid analysis of tail and liver tissues was performed
as previously described [50]. Briefly, frozen tissue sam-
ples were ground to a powder under liquid nitrogen
using a mortar and pestle. Lipid extraction and fatty acid
methylation was performed by the addition of 14% (w/v)
boron trifluoride (BF3)-methanol reagent (Sigma-Al-
drich) followed by heading at 100 °C for 1 h. Fatty acid
methyl esters (FAME) were analyzed using a fully auto-
mated HP5890 gas chromatography system equipped
with a flame-ionization detector (Agilent Technologies,
Palo Alto, CA). The fatty acid peaks were identified by
comparing their relative retention times with the com-
mercial mixed standards (NuChek Prep, Elysian, MN),
and area percentage for all resolved peaks was analyzed
by using a PerkinElmer M1 integrator.
Intestinal permeability
Intestinal permeability was performed as described pre-
viously [28]. Briefly, mice were fasted for 6 h and then
FITC-dextran (70kDA, Sigma-Aldrich, in PBS solution)
was administered to mice by oral gavage at a dose of
600 mg/kg body weight. Following gavage, blood sam-
ples were collected from the facial vein after 90 min.
Serum was diluted with an equal volume of PBS, and
fluorescence intensity was measured using a fluorospec-
trophotometer (PerkinElmer) with an excitation wave-
length of 480 nm and an emission wavelength of
520 nm. Serum FITC-dextran concentration was calcu-
lated from a standard curve generated by serial dilution
of FITC-dextran in PBS.
Serum LBP
Concentrations of lipopolysaccharide-binding protein
(LBP) in serum were assayed using a commercial ELISA
kit (NeoBioLab, Cambridge, MA) according to the man-
ufacturer’s instructions.
Stool DNA extraction and 16S rRNA gene sequencing
Bacterial genomic DNA was extracted from mice fecal
pellets using the QIAmp DNA Stool Mini Kit (Qiagen,
UK) according to the manufacturer’s instructions. DNA
was quantified and purification was subsequently assessed
by measuring absorbance and determining the A260/
A280 ratio. DNA was stored at − 20 °C until analysis.
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16S rRNA gene sequencing library preparation was
performed on DNA samples according to the Illumina
16S rRNA gene sequencing library protocol in order to
generate V3-V4 amplicons. DNA samples were subjected
to an initial PCR reaction utilizing primers specific for
amplification of the V3-V4 region of the 16S rRNA gene
(Forward primer 5′ TCGTCGGCAGCGTCAGATGTG
TATAAGAGACAGCCTACGGGNGGCWGCAG; reverse
primer 5′ GTCTCGTGGGCTCGGAGATGTGTATAA
GAGACAGGACTACHVGGGTATCTAATCC). Clean-up
and purification of the PCR product was performed using
the Agencourt AMPure XP system (Labplan, Dublin,
Ireland). Following clean-up and purification, a second
PCR reaction was performed in order to incorporate a
unique indexing primer pair to each sample (Illumina
Nextera XT indexing primers, Illumina, Sweden). The
PCR products were purified a second time using the
Agencourt AMPure XP system. Quantification of samples
was performed using the Qubit broad range DNA quan-
tification assay kit (Bio-Sciences, Dublin, Ireland). Follow-
ing quantification, samples were pooled in equimolar
amounts (10 nM) and sequenced at Clinical-Microbiomics
(Copenhagen, Denmark) using Illumina MiSeq 2 × 300 bp
paired-end sequencing.
16S rRNA gene sequencing bioinformatics analysis
The 64-bit version of USEARCH 8.1.1825 [51] and
mother v.1.36.1 [52] were used for bioinformatic analysis
of the sequence data. These were used in combination
with customized in-house programs, the process of
which is detailed precisely below.
Following tag identification and trimming (performed
natively in the sequencing machine), all sequences from
all samples were pooled using a perl script (bash com-
mand "cat", e.g. "cat *.R1.fastq > pool.R1.fastq"). Using
USEARCH’s—fastq_mergepairs command, paired-end
reads were merged, truncating reads at a quality score of
4, requiring at least 100 bp overlap and a merged read
length between 300 and 600 bp in length and less than
one expected errors in the merged read ("usearch8.1.
1825_i86osx64 -fastq_mergepairs pool.R1.fastq -reverse
pool.R2.fastq -fastq_minmergelen 300 -fastq_maxmerge-
len 600 -fastq_minovlen 100 -fastq_merge_maxee 1 -fas-
taout merged.fasta -relabel -"). Using mothur's trim.seqs
command, sequences with ambiguous bases, without
perfect match to the primers, or homopolymer length
greater than 8 were discarded and primer sequences
trimmed. Using USEARCH’s—derep_fulllength com-
mand, sequences were then strictly dereplicated discard-
ing clusters smaller than 5.
Using USEARCH’s—cluster_otus command, sequences
were clustered at 97% sequence similarity, using the
most abundant strictly dereplicated reads as centroids
(" usearch8.1.1825_i86osx64 -cluster_otus rua16s.sorted.fasta
-otus rua16s.clustered.fasta –uparseout rua16s.clustered.
table"). Using USEARCH’s—uchime_ref [53] command, sus-
pected chimeras were discarded based on comparison with
the Ribosomal Database Project classifier training set v9
[54]. Using mothur’s classify.seqs command, taxonomic as-
signment of OTUs was performed using the method by
Wang et al. [55] with mothur’s PDS version of the RDP
training database v14 ("classify.seqs(fasta=abrecovery.fasta,
template=otu.fasta, taxonomy=trainset14_032015.pds.fasta,
method=wang)"). The Wang parameters used were ksize =
8, iters = 100, and cutoff = 0. A bootstrap threshold of 80
was subsequently applied using R and values < 80 were
assigned as “unclassified”. Alpha diversity was calculated
using mothur’s Shannon command. To reduce bias from
variation in sample read numbers, samples were rarefied to
the sample with the lowest read count, 10,597 reads. Rar-
efaction can introduce bias into data and thereby affect out-
comes [56, 57]. To ensure our data processing did not affect
data outcomes, we performed PERMANOVA with Bray-
Curtis dissimilarity testing to examine whether rarifying
caused differences to the sequencing data. No significant dif-
ferences were observed between rarified and non-rarified
data. Similarly no significant differences were observed in
alpha diversity (Shannon index) or between any single OTU
(Kruskall-Wallis followed by Mann-Whitney testing) be-
tween rarified and non-rarified data.
Statistical analysis
Statistical analysis was performed using SPSS (v19, NY,
USA), GraphPad Prism (v6, CA, USA) and R (v3.2.4).
One-way analysis of variance (ANOVA) was performed
to assess differences between groups followed by Tukey’s
or LSD post-hoc test. Repeated-measures two-way
ANOVA (time and group) with Tukey’s post-hoc test
was used for weight gain data. For 16S rRNA gene se-
quencing data, principal coordinate analysis was con-
ducted using PAST Software (v3.18) with Bray-Curtis
dissimilarity testing. To assess whether significant differ-
ences existed between specific taxa, non-parametric ana-
lysis was performed using the Kruskall-Wallis test
followed by Mann-Whitney test. False discovery rate
(FDR) analysis was subsequently performed using the
Benjamani-Hochburg method and significance was cal-
culated at q < 0.05.
Linear discriminant analysis (LDA) effect size (LEfSe)
is a biomarker discovery tool for high-dimensional data
that provides effect size estimation [58]. Microbiota-
based biomarker analysis was performed with LEfSe
using the online galaxy server (https://huttenhower.sph.
harvard.edu/galaxy/). LDA scores (> 3.0) derived from
LEfSe analysis were used to show the relationship be-
tween taxon using a cladogram (circular hierarchical
tree). Levels of the cladogram represent, from the inner
to outer rings, phylum, class, order, family, and genus.
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For host-microbiome interaction analysis, an RV coeffi-
cient (a multivariate generalization of the Pearson correl-
ation coefficient) was calculated between the microbial
(pre- and post-HFD) and host parameters (mother and
offspring pre-HFD n-6/n-3 ratio, LBP, IP, and body
weight). The data was rescaled from 0 to 1 before analysis.
Pairwise correlations between each taxon and host
parameter were calculated using the Spearman’s non-
parametric rank correlation coefficient. Network-based
analytical approaches have been used previously to dis-
entangle host-microbe interactions [59, 60]. Data was
rescaled from 0 to 1 before analysis. Based on these cor-
relation coefficients, a correlation network (label adjust
and no overlap layout) was built where nodes represent
either a taxon or a host parameter. For each taxon and
host parameter, an undirected edge was added between
the corresponding nodes in the correlation network.
Edges (red links indicate positive and dark green links
indicate negative associations) represent statistically sig-
nificant correlations (P < 0.05). Correlations were calcu-
lated in PAST software version 2.17 and the network
was visualized in Gephi Graph Visualization and Ma-
nipulation software version 0.9.2. Nodes were colored
based on a “modularity” community detection algorithm.
A “module” in the network is a set of nodes connected
to each other by many links, while connected by few
links to nodes of other groups, so modules are elemen-
tary units of any biological network (each assigned a
unique color). Degree centrality of nodes was employed
as an index of node centrality.
Partial least squares regression (PLS-R) was used to asso-
ciate the microbial composition with host parameters in-
cluding jackknife-based variable selection as reported
previously [60]. For all models, the data were rescaled from
0 to 1 before PLS-R and centered as well as reduced during
PLS-R. Leave-one-out cross-validation (LOO-CV) was ap-
plied. The Q2 cumulated index (Q2cum) was used as a
measure of the global goodness of fit, the predictive quality
of the models and to test the validity of the model against
over-fitting. A Q2cum threshold of > 0.8 was applied. The
resulting plot displays the dependent variables on the c
vectors and the explanatory variables on the w* vectors
which allows visualizing the global relationship between the
variables. The w* are related to the weights of the
variables in the models. The results are also presented in
PLS scatter plots for subject clustering and variables. The
R2 (coefficient of determination) indicates the percentage
of variability of the dependent variable (Y) which is
explained by the explanatory variables (X). The relative
importance of each x-variable is expressed by variable
importance in the projection (VIP) values. VIP-value 1 or
> 1.0 is considered influential and > 1.5 as highly influen-
tial. Results of all of the above mentioned statistics were
given in the Supplementary file 6. All analyses were
performed using precise algorithm in the XLSTAT soft-
ware version 2017.6.
Associations between the host and microbiome data
sets were also assessed by multiple factor analysis
(MFA). The methodology of the MFA breaks up into
two phases: (i) a principal component analysis (PCA)
(Spearman type) successively carried out for each dataset
(Dataset 1, host parameters; Dataset 2, pre- and post-
HFD microbiota data) which stores the value of the first
eigenvalue of each analysis to then weigh the various
datasets in the second part of the analysis. (ii) A
weighted PCA on the columns of all the datasets leads
to each indicator variable having a weight that is a func-
tion of the frequency of the corresponding category.
After these two phases, the coordinates of the projected
points in the space resulting from the MFA are dis-
played. The projected points correspond to projections
of the observations in the spaces reduced to the dimen-
sions of each dataset. Based on the eigenvalues of the
weighted PCA, the first two factors (F1/F2) almost cov-
ered 60% of the variability in this analysis. To test
whether the four groups with superimposed host and
microbiome data were separated from each other,
Kruskal-Wallis testing was performed on the coordinates
of the projected points and p values were obtained using
10,000 Monte Carlo permutations. One end of each line
for an observation indicates the host parameters (differ-
ently colored to indicate the groups) and another end
(red) indicates the microbiota.
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